Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Reexamination Certificate
2005-07-29
2010-12-07
Harris, Alana M (Department: 1643)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
C424S184100, C424S234100, C424S239100, C424S247100, C514S002600
Reexamination Certificate
active
07846456
ABSTRACT:
A method for treating a mammary gland disorder, including hyperplastic, hypertonic, cystic and/or neoplastic mammary gland tissue by local administration of a botulinum toxin to or to the vicinity of the afflicted breast tissue.
REFERENCES:
patent: 5183462 (1993-02-01), Borodic
patent: 5437291 (1995-08-01), Pasricha et al.
patent: 5670484 (1997-09-01), Binder
patent: 5766605 (1998-06-01), Sanders et al.
patent: 6063768 (2000-05-01), First
patent: 6139845 (2000-10-01), Donovan
patent: 6312708 (2001-11-01), Donovan
patent: 2001/0043930 (2001-11-01), Aoki et al.
patent: 19802569 (1998-01-01), None
patent: 2142032 (1985-01-01), None
patent: 2142032 (1985-01-01), None
patent: WO 94/24155 (1994-10-01), None
patent: WO 00/33880 (2000-06-01), None
patent: 01 21213 (2001-03-01), None
patent: WO 02/07759 (2002-01-01), None
patent: WO 02/09743 (2002-02-01), None
patent: WO 02/074327 (2002-09-01), None
patent: WO 02/074327 (2002-09-01), None
Johnson (Neurotoxigenic Clostridia. In: Fischetti, V.A. (EDS) Gram-Positive Pathogens. ASM Press, Washington, DC. pp. 539-550).
Hatheway (Clinical Microbiology Reviews 3(1): 66-98, Jan. 1990).
Gura. Systems for Identifying New Drugs Are Ofter Faulty. Science 278: 1041 and 1042, Nov. 7, 1997.
Bodey et al. Failure of Cancer Vaccines: The Significant Limitations of this Approach to Immunotherapy. Anticancer Research 20: 2665-2676, 2000.
Chamberlain and Kaufman. Innovations and stategies for the development of anticancer vaccines. Exp. Opin. Pharmacother. 14: 603-614, 2000.
Wald and Kakulas. Apocrine gland carcinoma (sweat gland carcinoma) of the breast. The Australian and New Zealand Journal of Surgery 33(3): 200-201, Feb. 1964.
Richards, A., et al.,Plastic and Reconstructive Surgery, Jul. 2001 pp. 270-271, “Botox for contraction of pectoralmuscles”.
Schwartz, M.S., et al.,Movement Disorders, vol. 13, No. 1, 1998, pp. 188-190, “Neuromyotonia in a muscle flap producing a convulsing breast: successful treatment with botulinum toxin”.
Senior, M.A., et al.,Plastic and Reconstructive Surgery, Jul. 2000, pp. 224-225, “Botox and the management of pectoral spasm after subpectoral implant insertion”.
Andersson, J., et al.,Differential sorting of SNAP-25a and SNAP-25b proteins in neuroblastoma cells, European Journal of Cell Biology 79, 781-789 (Nov. 2000).
Bagshawe, K.D. et al.,Antibody directed enzyme prodrug therapy(ADEPT):Clinical Report, Disease Markers, vol. 9, 233-238 (1991).
Bagshawe, K.D., et al.,A cytotoxic agent can be generated selectively at cancer sites, Br. J. Cancer (1988) 58. 700-703.
Balakina, G.B., et al.Localization of Choline Acetyltransferase in the alveolar portio nof th emammary gland of the white mouse, Arkh Anat Gistol Embriol Apr. 1986; 90(4): 73-77—Russian.
Bigalke, H., et al.,Botulinum A Neurotoxin Inhibits Non-Cholinergic Synaptic Transmission in Mouse Spinal Court Neurons in Culture, Brain Research, 360 (1985) 318-324, Elsevier.
Bigalke, H., et al.,Tetanus Toxin and Botulinum A Toxin Inhibit Release and Uptake of Various Transmitters, as Studied with Particulate Preparations from Rat Brain and Spinal Cord, Naunyn-Schmiedeberg's Arc Pharmacol (1981) 316:244-251.
Boyd, R.S., et al.,The Effect of Botulinum Neurotoxins on the Release of Insulni from the Insulinoma Cell Lines HIT-15 and RINm5F, The American Society for Biochemistry and Molecular Biology, Inc., 18216-18218, Aug. 4, 1995, vol. 270, No. 31.
Bryan, M.,Glomus Tumors, Dept. of Otolaryngology, UTMB, Jan. 11, 1995 10 pgs.
Cabello, G., et al.,A Rat Mammary Tumor Model Induced by the Organophosphorous Pesticides Parathion and Malathion, Possibly through Acetylcholinesterase Inhibition, Environmental Health Perspectives, vol. 109 No. 5, May 2001.
Col, V., et al.,Heart Failure Induced by Pheochromocytoma: Laparoscopic Treatment and Intraoperative Changes of Several New Cardiovascular Hormones, Hormone Research, 1999; 51:51-52.
Cukan, M., et al.,Expression of SNAP-23 and SNAP-25 in the Pancreatic Acinar Tumor Cell Line AR42J, Molec Biol Cell 1999;20(Suppl):398a.
Der, R., et al.,Gastric Neoplasms, Gastrointestinal Pathology, (1999) pp. 105-144.
Dorosevich, A.E., et al.,Autonomic Nerve Endings and Their Cell Microenvironment as one of the integral parts of the stromal component in breast dysplasia and cancer, Arkh Patol Nov.-Dec. 1994;56(6):49-53—Russian.
Duggan, M.J., et al.,A survey of botulinum neurotoxin substrate expression in cells, Mov Disord May 1995; 10(3):376.
Ellis, I.O., et al.,Tumors of the Breast, Diagnostic Histopathology of Tumors, vol. 1, 2nded. 2000, pp. 865-930.
Eccles, S.A., et al.,Regression of Established Breast Carcinoma Xenografts with Antibody-directed Enzyme Prodrug Therapy against C-erbB2 p1851Cancer Research 54, 5171-5177, Oct. 1, 1994.
Fabian, C.J., et al.,Beyond Tamoxifen New Endpoints for Breast Cancer Chemoprevention, New Drugs for Breast Cancer Prevention, Ann NY Acad Sci 2001; 952: 44-59.
Foran, P., et al.,Blockade by Botulinum Neurotoxin B of Catecholamine Release from Adrenochromaffin Cells Correlates with its Cleavage of Synaptobrevin and a Homologue Present on the Granules, Biochemistry 1995, 34, 5494-5503.
Gil, A., et al.,Dual effects of botulinum neurotoxin A on the secretory stages of chromaffin cells, European Journal of Neuroscience, vol. 10, pp. 3369-3378, 1998.
Goodall, Neuroblastoma A.R., et al.,Occurrence of Two Types of Secretory Vesicles I the Human Neuroblastoma SH-SY5Y, Journal of Neurochemistry, vol. 68, No. 4, 197, pp. 1542-1552.
Graff, L., et al.,Expression of Vesicular Monamine Transporters, Synaptosomal-assocated Protein 25 and Syntaxin1 : a Signature of Huam Small Cell Lung Carcinoma, Cancer Research 61, pp. 2138-2144, Mar. 1, 2001.
Grosse, J., et al.,Synaptosome-Associate Protein of 25 Kilodaltons in Oocytes and Steroid-Producing Cells of Rat and Human Ovary: Molecular Analysis and Regulation by Gonadotropins, Biology of Reproduction 63, 643-650 (2000).
Habermann, E., et al.,Tetanus Toxin,and Botulinum A and C Neurotoxins Inhibit Noradrenaline Release from Cultured Mouse Brain, Journal of Neurochemistry, vol. 51, No. 2, 1988.
Hallett, M.,One Man's Poison—Clinical Applications of Botulinum Toxin, New England Journal of Medicine, Jul. 8, 1999, pp. 118-120.
Heppner, F.,New Technologies to Combat Malignant Tumours of the Brain, Anticancer Research, 2: 101-110 (1982).
Heppner, F., et al.,The Liquefaction(Oncolysis)of Malignant Gliomas by a Non Pathogenic Clostridium, ACTA Neurochirurgica 42, (1978) pp. 123-125.
Huang, X., et al.,Truncated SNAP-25(1-197),Like Botulinum Neurotoxin A, Can Inhibit Insulin Secretion from HIT-T15 Insulinoma Cells, Molecular Endocrinology, 1998, vol. 12 No. 7, pp. 1060-1070.
Jankovic, J., et al., editors,Therapy with Botulinum Toxin, Marcel Dekker, Inc., publisher; p. 45 (1994).
Johnson, R K., et al.,The clinical impact of screening and other experimental tumor studies, Cancer Treatment Reviews (1975) 2, pp. 1-31.
John, H., et al.,Pheochromocytomas: can malignant potential be predicted?, Elsevier Science, Inc. Urology 53 (4), 1999, pp. 679-683.
Laskawi, R.,Up-to-date Report of Botulinum Toxin Type A Treatment in Patients With Gustatory Sweating(Frey's Syndrome), Laryngoscope 108: Mar. 1998, pp. 381-384.
Lemmon, M.J., et al.,Anaerobic bacteria as a gene delivery system to tumors, Proceedings of the American Association for Cancer Research, #2231, Experimental Therapeutics, p. 374, vol. 35, Mar. 1994.
Lin, J.C., et al.,Cardiac Pheochromocytoma: Resection after Diagnosis by 111-Indium Octreotide Scan, Ann Thorac Surg 1999; 67:555-8.
Majo, G., et al.,Immunocytochemical Analysis of the Synaptic Proteins SNAP-25 and Rab3A in Human Pituitary Adenomas. Overexpression of Snap-25 in the Mammosomatotroph Lineages, Journal of Pathology, vol. 183: 440-446 (1997).
Maksymowych, A.B., et al.,Binding and Transcytosis of Botulinum Neurotoxin by Polarized Human Colon Carcinoma Cells, The Journal of Biological Chemistry, vol. 273, No. 34 Aug. 21, pp. 21950-21957, 1998.
Meyer, K.E.,A Comparative Systemic Toxicity Study of Neurobloc in Adult and Juvenile Cynomolgus M
Brin Mitchell F.
Donovan Stephen
Abel Kenton
Allergan Inc.
Condino Debra
Harris Alana M
Nassif Claude L.
LandOfFree
Methods for breast treatment does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for breast treatment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for breast treatment will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4195552